Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Estcourt, Lise J ^a   Desborough, Michael ^a   Hopewell, Sally ^b   Doree, Carolyn ^a   Stanworth, Simon J ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CENTRAL VENOUS CATHETERIZATION; CHRONIC LIVER DISEASE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; HUMAN; PLATELET COUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; ARTICLE; CLINICAL PROTOCOL; DATA COLLECTION METHOD; EXPERIMENTAL DESIGN; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; BLOOD; CENTRAL VENOUS CATHETER; CHRONIC DISEASE; HEMORRHAGE; LIVER CIRRHOSIS; THROMBOCYTE COUNT;

CENTRAL VENOUS CATHETERS; CHRONIC DISEASE; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; PLATELET COUNT; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOCYTOPENIA;

EID: 84962967718     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011771.pub2     Document Type: Review

References (59)

1. Adorno G, Zinnio F, Bruno A, Lanti A, Ballatore G, Masi M, et al. Femoral catheters: safety and efficacy in peripheral blood stem cell collection. The International Journal of Artifical Organs 1999;22(10):710-12.
2. Amarapurkar D, Shah A, Dharod M, Chandanani MR, Baijal R, Kumar P, et al. Coagulopathy in cirrhosis: a prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics. Gastroenterology. 2014:S737.
3. Amarapurkar D, Shah A, Dharod M, Chandanani MR, Baijal R, Kumar P, et al. Coagulopathy in cirrhosis: a prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics. Hepatology International. 2014:S371-2.
4. Barrera R, Mina B, Huang Y, Groeger JS. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 1996;78(9):2025-30.
5. Barrett AM, Imeson J, Leese D, Philpott C, Shaw ND, Pizer BL, et al. United Kingdom Children's Cancer Study Group and the Paediatric Oncology Nurses Forum of the Royal College of Nursing. Factors influencing early failure of central venous catheters in children with cancer. Journal of Pediatric Surgery 2004;39:1520-3.
6. Blumberg N, Heal JM, Rowe JM. Platelet transfusion and clinical outcome in acute leukemia in adults. Transfusion. 2002; Vol. 42:5S.
7. Napolitano G, Valvano MR, Caruso N, Merla A, Lauriola WA Ippolito A, et al. Hemorrhagic complications following invasive procedures in cirrhotic patients with normal or abnormal coagulopathy. A prospective study. Journal of Hepatology. 2012; Vol. 56:S262.
8. Napolitano M, Malato A, Raffaele F, Palazzolo M, Lo Iacono G, Pinna R, et al. Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia. Blood Transfusion 2013;11:506-9.
9. Natalia N, Garcia SJ, Guillen H, Martin Y, Callejas M, Gil FJJ, et al. A team-based, multidisciplinary approach to reducing peripherally-inserted central catheters (PICC) complications in haematological patients: a prospective study. 17th Congress of the European Hematology Association Amsterdam Netherlands. Haematologica. 2012.
10. NCT01615146. Outpatient platelet transfusions in myelodysplastic syndromes and leukemia: the OPTIMAL pilot. http://ClinicalTrials.gov/show/NCT01615146. Accessed 25 Feb. 2015.
11. Potet J, Thome A, Curis E, Arnaud FX, Weber-Donat G, Valbousquet L, et al. Peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis. European Journal of Radiology 2013;23:2042-8.
12. Ray CE Jr, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 1997;204:97-9.
13. Schiffer CA. What to do if there is no evidence? The issue of surgical procedures in patients with thrombocytopenia. Transfusion 2011;51:2262-4.
14. Slichter SJ. Prophylactic platelet transfusion. ANZSBT abstracts presented at the HSANZ/ANZSBT/ASTH ISH Annual Scientific Meeting 2011 held 30 October to 2 November 2011 in Sydney, Australia. Transfusion Medicine. 2012; Vol. 22:221.
15. NCT00448188. Bleeding risk in CVCs. Clinical.Trials.gov [Accessed 25 Feb. 2015].
16. Weigand K, Encke J, Meyer FJ, Hinkel UP, Munder M, Stremmel W, et al. Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters. Medizinische Klinik (Munich) 2009;104(5):331-5.
17. Zeidler K, Arn K, Senn O, Schanz U, Stussi G. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion 2011;51(11):2269-76.
18. Rocha LL, Correa TD. Comparison of three transfusion strategies for central venous catheterization in cirrhotics (POCKET). Clinicaltrial.gov [Accessed 25 Feb. 2015] 2014.
19. BCSH. British Committee for Standards in Haematology: guidelines for the use of platelet transfusions. British Journal of Haematology 2003;122(1):10-23.
20. Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. British Journal of Haematology 2009;147(4):431-43.
21. Bishop L, Dougherty L, Bodenham A, Mansi J, Crowe P, Kibbler C, et al. Guidelines on the insertion and management of central venous access devices in adults. International Journal of Laboratory Hematology 2007;29:261-78.
22. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell -CD40 ligand and transfusion immune modulation. Immunology Research 2009;45:251-60.
23. Bolton-Maggs PHB (Ed), Cohen H, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report. Serious Hazards of Transfusion (SHOT), 2012.
24. Bosly A, Muylle L, Noens L, Pietersz R, Heim D, Hübner R, et al. Guidelines for the transfusion of platelets. Acta Clinica Belgica 2007;62(1):36-46.
25. Cameron B, Rock G, Olberg B, Neurath D. Evaluation of platelet transfusion triggers in a tertiary-care hospital. Transfusion 2007;47(2):206-11.
26. Cavanna L, Civardi G, Vallisa D, Di Nunzio C, Cappuciati L, Berte R, et al. Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1, 978 consecutive catheterizations. World Journal of Surgical Oncology 2010;8:91. [DOI: 10.1186/1477-7819-8-91]
27. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
28. Evidence Partners. DistillerSR: Data Management Software. Ottawa, ON: Evidence Partners, 2015.
29. Estcourt LJ, Birchall J, Lowe D, Grant-Casey J, Rowley M, Murphy MF. Platelet transfusions in haematology patients: are we using them appropriately?. Vox Sanguinis 2012;103(4):284-93.
30. Foster P, Moore L, Sankary H, Hart M, Ashmann M, Williams J. Central venous catheterization in patients with coagulopathy. Archives of Surgery 1992;127(3):273-5.
31. The Board of the German Medical Association on the recommendation of the Scientific Advisory Board. Platelet transfusions. Transfusion Medicine and Hemotherapy 2009;36:372-82.
32. Greeno E, McCullough J, Weisdorf D. Platelet utilisation and the transfusion trigger: a prospective analysis. Transfusion 2007;47(2):201-5.
33. Haas B, Chittams J, Trerotola S. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. Journal of Vascular and Interventional Radiology 2010;21(2):212-7.
34. Heddle NM, Webert K. Investigation of acute transfusion reactions. In: Murphy MF, Pamphilion DH editor(s). Practical Transfusion Medicine. 4th Edition. Blackwell, 2009:63-89.
35. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
36. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
37. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
38. Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C, et al. Ultrasonic locating devices for central venous canulation: meta-analysis. BMJ 2003;327(7411):361.
39. Hong Pheng Loh A, Hon Chui C. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity?. Journal of Pediatric Surgery 2007;42:1180-4.
40. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015;162(3):205-13.
41. Khan H, Belsher J, Yilmaz M, Afessa B, Winters J, Moore S, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007;131(5):1308-14.
42. Knowles S, Cohen H, Serious Hazards of Transfusion (SHOT) Steering Group. The 2010 Annual SHOT Report. Serious Hazards of Transfusion (SHOT), 2011.
43. Lau J, Ioannidis J, Terrin N, Schmid C, Olkin I. The case of the misleading funnel plot. BMJ 2006;333(7568):597-600.
44. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
45. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA Statement. Annals of Internal Medicine 2009;151(4):264-9.
46. Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
47. Pearce S, Rowe GP, Field SP. Screening of platelet for bacterial contamination at the Welsh Blood Service. Transfusion Medicine 2011;21(1):25-32.
48. Pendry K, Davies T. An audit of use and wastage in the north west of England and North Wales: where have all the platelets gone?. Blood and Transplant Matters 2011;34:17-9.
49. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
50. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
51. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
52. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
53. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101(2):454-62.
54. Smith RN, Nolan JP. Central venous catheters. BMJ 2013;347:f6570. [DOI: 10.1136/bmj.f6570]
55. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion 2013;53(5):1050-8.
56. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
57. Taylor C, Cohen H, Mold D, Jones H, Ball J, Mistry H, et al. Serious Hazards of Transfusion (SHOT) Steering Group. The 2009 Annual SHOT Report. Serious Hazards of Transfusion (SHOT), 2010.
58. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; Vol. 8, issue 16. [DOI: 10.1186/1745-6215-8-16]
59. Estcourt LJ, Desborough M, Hopewell S, Trivella M, Doree C, Stanworth S. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD011771]